KEGG    Network variation - TRH-TSH-TH signaling
[ Network menu | Network entry | Help ]
ENTRYnt06322
NameTRH-TSH-TH signaling
CategoryPathway view; Endocrine system
Pathwayhsa04918 Thyroid hormone synthesis
DiseaseH00250 Congenital nongoitrous hypothyroidism (CHNG)
H00251 Thyroid dyshormonogenesis
Display drug-target relation   disease type
N00918    TRHTRHRGNAQ/11PLCB(Ca2+,DAG)PKCTSHB
    CHNG   TRHR*
 
N00782    TSHBTSHRGNASADCYcAMPPKA(TTF1,TTF2,PAX8,CR..TG
    CHNG TSHB*
    CHNG   TSHR*
    Congenital hyperthyroidism   TSHR*
    CHNG             PAX8*
 
N00793    TSHBTSHRGNAQPLCB(Ca2+,DAG)PKCDUOX2H2O2TG
                DUOX2*
N00795              DUOXA2DUOX2H2O2
              DUOXA2*
 
N00786    Iodide(blood)(SLC5A5,SLC26A4)Iodide
      SLC5A5*
      SLC26A4*
 
   D3,D4
 |
   D3,D4
 |
  
N00803    TG+(Iodide+Tyr)TPOTG+(MIT,DIT)TPOTG+(T3,T4)
    TG*
N00789    TG+(Iodide+Tyr)TPO*TG+(MIT,DIT)TPO*TG+(T3,T4)
 
N00791    (MIT,DIT)IYDIodide
      IYD*
 
     D1,D2
 |
    
N00798    (SLC16A10,SLC16A2)T3(THRB,THRA)=RXR(MYH6,ATP2A2)
    AHDS SLC16A2*
    CHNG     THRA*
    Thyroid hormone resistance syndrome     THRB*

Disease nameDisease category
CHNGH00250Congenital nongoitrous hypothyroidism (CHNG)Endocrine and metabolic disease
Congenital hyperthyroidismH01269Congenital hyperthyroidismEndocrine and metabolic disease
Thyroid dyshormonogenesisH00251Thyroid dyshormonogenesisEndocrine and metabolic disease
AHDSH00650Allan-Herndon-Dudley syndromeEndocrine and metabolic disease
Thyroid hormone resistance syndromeH00249Thyroid hormone resistance syndromeEndocrine and metabolic disease


Drug name
D1D01010Levothyroxine sodium (USP)
D2D01011Liothyronine sodium (JP18/USP)
D3D00401Methimazole (USP)
D4D00562Propylthiouracil (JP18/USP/INN)